Abstract
Prednisolone given universally for COPD exacerbations causes harm without any benefit. Patients deserve blood eosinophil-guided prednisolone treatment for COPD exacerbations.
Document Type
Editorial
Date of Publication
1-1-2023
Volume
9
Issue
5
Publication Title
ERJ Open Research
Publisher
European Respiratory Society
School
School of Medical and Health Sciences
Funders
AstraZeneca
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Ramakrishnan, S. (2023). Prednisolone for COPD exacerbations: time for a rethink. ERJ Open Research, 9(5). https://doi.org/10.1183/23120541.00464-2023